Cargando…

External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection

BACKGROUND: No postoperative cardiopulmonary morbidity models have been developed or validated in Chinese patients with lung resection. This study aims to externally validate five predictive models, including Eurolung models, the Brunelli model and the Age-adjusted Charlson Comorbidity Index, in a C...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Guanghua, Liu, Lei, Wang, Luyi, Wang, Zhile, Wang, Zhaojian, Li, Shanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840067/
https://www.ncbi.nlm.nih.gov/pubmed/35186502
http://dx.doi.org/10.7717/peerj.12936
_version_ 1784650526637424640
author Huang, Guanghua
Liu, Lei
Wang, Luyi
Wang, Zhile
Wang, Zhaojian
Li, Shanqing
author_facet Huang, Guanghua
Liu, Lei
Wang, Luyi
Wang, Zhile
Wang, Zhaojian
Li, Shanqing
author_sort Huang, Guanghua
collection PubMed
description BACKGROUND: No postoperative cardiopulmonary morbidity models have been developed or validated in Chinese patients with lung resection. This study aims to externally validate five predictive models, including Eurolung models, the Brunelli model and the Age-adjusted Charlson Comorbidity Index, in a Chinese population. METHODS: Patients with lung cancer who underwent anatomic lung resection between 2018/09/01 and 2019/08/31 in our center were involved. Model discrimination was assessed by the area under the receiver operating characteristic curve. Model calibration was evaluated by the Hosmer–Lemeshow test. Calibration curves were plotted. Specificity, sensitivity, negative predictive value, positive predictive value and accuracy were calculated. Model updating was achieved by re-estimating the intercept and/or the slope of the linear predictor and re-estimating all coefficients. RESULTS: Among 1085 patients, 91 patients had postoperative cardiopulmonary complications defined by the European Society of Thoracic Surgeons. For original models, only parsimonious Eurolung1 had acceptable discrimination (area under the receiver operating characteristic curve = 0.688, 95% confidence interval 0.630–0.745) and calibration (p = 0.23 > 0.05) abilities simultaneously. Its sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 0.700, 0.649, 0.153, 0.960 and 0.653, respectively. In the secondary analysis, increased pleural effusion (n = 94), which was nonchylous and nonpurulent, was labeled as a kind of postoperative complication. The area under the receiver operating characteristic curve of the models increased slightly, but all models were miscalibrated. The original Eurolung1 model had the highest discrimination ability but poor calibration, and thus it was updated by three methods. After model updating, new models showed good calibration and small improvements in discrimination. The discrimination ability was still merely acceptable. CONCLUSIONS: Overall, none of the models performed well on postoperative cardiopulmonary morbidity prediction in this Chinese population. The original parsimonious Eurolung1 and the updated Eurolung1 were the best-performing models on morbidity prediction, but their discrimination ability only achieved an acceptable level. A multicenter study with more relevant variables and sophisticated statistical methods is warranted to develop new models among Chinese patients in the future.
format Online
Article
Text
id pubmed-8840067
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-88400672022-02-17 External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection Huang, Guanghua Liu, Lei Wang, Luyi Wang, Zhile Wang, Zhaojian Li, Shanqing PeerJ Oncology BACKGROUND: No postoperative cardiopulmonary morbidity models have been developed or validated in Chinese patients with lung resection. This study aims to externally validate five predictive models, including Eurolung models, the Brunelli model and the Age-adjusted Charlson Comorbidity Index, in a Chinese population. METHODS: Patients with lung cancer who underwent anatomic lung resection between 2018/09/01 and 2019/08/31 in our center were involved. Model discrimination was assessed by the area under the receiver operating characteristic curve. Model calibration was evaluated by the Hosmer–Lemeshow test. Calibration curves were plotted. Specificity, sensitivity, negative predictive value, positive predictive value and accuracy were calculated. Model updating was achieved by re-estimating the intercept and/or the slope of the linear predictor and re-estimating all coefficients. RESULTS: Among 1085 patients, 91 patients had postoperative cardiopulmonary complications defined by the European Society of Thoracic Surgeons. For original models, only parsimonious Eurolung1 had acceptable discrimination (area under the receiver operating characteristic curve = 0.688, 95% confidence interval 0.630–0.745) and calibration (p = 0.23 > 0.05) abilities simultaneously. Its sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 0.700, 0.649, 0.153, 0.960 and 0.653, respectively. In the secondary analysis, increased pleural effusion (n = 94), which was nonchylous and nonpurulent, was labeled as a kind of postoperative complication. The area under the receiver operating characteristic curve of the models increased slightly, but all models were miscalibrated. The original Eurolung1 model had the highest discrimination ability but poor calibration, and thus it was updated by three methods. After model updating, new models showed good calibration and small improvements in discrimination. The discrimination ability was still merely acceptable. CONCLUSIONS: Overall, none of the models performed well on postoperative cardiopulmonary morbidity prediction in this Chinese population. The original parsimonious Eurolung1 and the updated Eurolung1 were the best-performing models on morbidity prediction, but their discrimination ability only achieved an acceptable level. A multicenter study with more relevant variables and sophisticated statistical methods is warranted to develop new models among Chinese patients in the future. PeerJ Inc. 2022-02-09 /pmc/articles/PMC8840067/ /pubmed/35186502 http://dx.doi.org/10.7717/peerj.12936 Text en ©2022 Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Oncology
Huang, Guanghua
Liu, Lei
Wang, Luyi
Wang, Zhile
Wang, Zhaojian
Li, Shanqing
External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection
title External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection
title_full External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection
title_fullStr External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection
title_full_unstemmed External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection
title_short External validation of five predictive models for postoperative cardiopulmonary morbidity in a Chinese population receiving lung resection
title_sort external validation of five predictive models for postoperative cardiopulmonary morbidity in a chinese population receiving lung resection
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840067/
https://www.ncbi.nlm.nih.gov/pubmed/35186502
http://dx.doi.org/10.7717/peerj.12936
work_keys_str_mv AT huangguanghua externalvalidationoffivepredictivemodelsforpostoperativecardiopulmonarymorbidityinachinesepopulationreceivinglungresection
AT liulei externalvalidationoffivepredictivemodelsforpostoperativecardiopulmonarymorbidityinachinesepopulationreceivinglungresection
AT wangluyi externalvalidationoffivepredictivemodelsforpostoperativecardiopulmonarymorbidityinachinesepopulationreceivinglungresection
AT wangzhile externalvalidationoffivepredictivemodelsforpostoperativecardiopulmonarymorbidityinachinesepopulationreceivinglungresection
AT wangzhaojian externalvalidationoffivepredictivemodelsforpostoperativecardiopulmonarymorbidityinachinesepopulationreceivinglungresection
AT lishanqing externalvalidationoffivepredictivemodelsforpostoperativecardiopulmonarymorbidityinachinesepopulationreceivinglungresection